|
|
| Cocaine addiction drug trial begins |
| By South Florida Business Journal |
| Published: 07/10/2007 |
|
TALLAHASSEE, FL - Catalyst Pharmaceutical Partners has started the Phase II clinical trial for its drug candidate to treat cocaine addiction. Ten addiction treatment clinics nationwide will enroll about 180 cocaine-dependent patients in the trial for CPP-109, also known as vigabatrin.Read more. If link has expired, check the website of the article's original news source. |
MARKETPLACE search vendors | advanced search
IN CASE YOU MISSED IT
|
Comments:
No comments have been posted for this article.
Login to let us know what you think